The Translational Genomics Research Institute May 7 2026 The Translational Genomics Research Institute (TGen), part of City of Hope, today announced the launch of JAYseq TM , a clinical whole-genome sequencing (WGS) test specifically for multiple myeloma. Approximately 35,000 new cases of multiple myeloma are diagnosed annually in the U.S., making it the second-most common blood cancer. The JAYseq test, developed and performed by TGen Clinical Laboratory, a CAP‑accredited lab founded by TGen,